Solagran Limited (ASX:SLA) Announce Unexpected Efficacy Of Ropren In Treating Severe Alcoholism
Feb 18th 2008Drug InformationAlcohol / Addiction / Illegal Drugs
The Directors of Solagran Limited (ASX: SLA) are pleased to provide a summary of the results of the Ropren clinical trials conducted at the Skvortsova-Stepanova psychiatric hospital in 2006-07 with serious and critically ill, drug addicted chronic alcoholics.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
